The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc's remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker's global donation.
- The U.S. Department of Health and Human Services said on Saturday it would allow state health departments to distribute Gilead Sciences Inc’s remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker’s global donation.
Gilead has committed to supply approximately 607,000 vials of remdesivir over the next six weeks in the United States, and the U.S. state health department will distribute the doses to appropriate hospitals in their states, HHS said. Last Friday, the U.S. Food and Drug Administration gave emergency use authorization for the drug for patients with severe COVID-19, clearing the way for broader use in more hospitals around the United States. Data has shown Gilead’s antiviral drug remdesivir helped to reduce hospital stays for COVID-19 patients.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vietnam and the Indian state of Kerala curbed covid-19 on the cheapTheir secret is quick and efficient public-health systems
Read more »
This Single Dad Truly Stepped Up During The COVID-19 PandemicThis Unconventional Family Took In A Foster Child During The Pandemic
Read more »
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus TestThe FDA granted its first-ever emergency use authorization for the gene-editing technology Crispr—greenlighting a coronavirus diagnostic test developed by Cambridge, Massachusetts-based Sherlock Biosciences
Read more »
Yes, COVID-19 is mutating, here's what you need to knowAs the virus that causes COVID-19 traveled out of China and proliferated across the globe, it developed small mutations that accumulated into distinct versions.
Read more »